Home » Medical Devices » Transdermal Skin Patches Market

Transdermal Skin Patches Market By Product (Matrix, Drug In Adhesive, Reservoir, Multilaminate), By Application (Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Motion Sickness, Neurological Disorder, Cardiovascular Disorder) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Price: $4999

Published: | Report ID: 11583 | Report Format : PDF

Market Insights

Transdermal skin patches are medicated, adhesive patch that is placed on the skin to deliver a specific dose of medicine through the skin and into the bloodstream. The patch contains the medication prescribed to the patient and is designed in such a way that the medication permeates the skin in a controlled fashion, thus attaining more steady levels of the drug in the body.

The report titled “Global Transdermal Skin Patches Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall transdermal skin patch market, along with the market size and estimates for the duration of 2017–2025. The research study covers an in-depth analysis of market segments based on product type, application type, and different geographical regions.

The report also includes sections on the competitive profiling of the leading players in the global transdermal skin patches market, attractive investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.

Geographically, the global transdermal skin patch market is studied for the following regional markets:

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global transdermal skin patch market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global transdermal skin patch market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global transdermal skin patch market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global transdermal skin patches market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Based on the type of product, the transdermal skin patches market is segmented into:

  • Matrix
  • Drugs in Adhesives
  • Reservoir
  • Vapor

Transdermal patches are medicated adhesive patches that are placed on the skin to deliver a specific dose of medicine through the skin and into the bloodstream. The patch contains the medication prescribed to the patient and is designed in such a way that the medication permeates the skin in a controlled fashion, thus attaining more steady levels of the drug in the body. Currently, patches are being marketed that can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.

The transdermal skin patches market is classified into the matrix, drug in the adhesive, reservoir, and vapor products. The matrix segment held the largest share in the overall transdermal skin patch market due to product modifications in terms of controlled release settings. Moreover, the non-toxic and non-antagonistic characteristics of polymer matrix options, which are known to diffuse drugs with controlled precision, would further drive the market in the future.

Based on the type of application, the transdermal skin patches market is segmented into:

  • Pain Relief
  • Nicotine Cessation
  • Hormone replacement therapy
  • Motion Sickness
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others

Transdermal skin patches offer many advantages over other drug delivery methods like pills, powder, or liquid medication. The most vital benefit of skin patches is that they deliver the drug directly into the bloodstream, bypassing the liver’s metabolic activity. The second benefit of using patches is that medication is supplied gradually and constantly rather than in a large, single dose, which is advised in many therapeutic conditions. On the basis of application, the transdermal skin patches are segmented into pain relief, nicotine cessation, hormone replacement therapy, motion sickness, neurological disorders, cardiovascular disorders, and others.

Transdermal patches for pain relief are the major contributing market, as they are preferred over hypodermic injections, which are more painful, generate medical waste, and pose a risk of disease transmission. Improved patient compliance as the treatment is non-invasive, simple, and convenient, and there is greater flexibility in the termination of drugs with the removal of patches.

For the purpose of this study, the global market for transdermal skin patches is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

For the purpose of this study, the global market for transdermal skin patches is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In the base year 2016, North America dominated the global medical foods market, which was followed by Europe. The key market drivers assisting in the growth of transdermal skin patches in North America comprise the rise in research and development in non-invasive methods of treatment for chronic conditions such as pain relief, motion sickness, and other lifestyle-related disorders.

Moreover, in developed countries like the U.S., the U.K., and others in North America and Europe, the adoption rate of non-invasive and novel treatments is higher than in developing nations. However, Asia Pacific has emerged as the fastest-growing region in the transdermal skin patch market due to rising demand for better treatment at an affordable cost in the region. Furthermore, innovation and government funding in the development of cutting-edge technology and healthcare infrastructure would augment the growth of the Asia-Pacific transdermal skin patch market.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Transdermal Skin Patches Market Portraiture
2.2 Transdermal Skin Patches Market, by Product Type, 2016 (US$ Mn)
2.3 Transdermal Skin Patches Market, by Application Type, 2016 (US$ Mn)
2.4 Transdermal Skin Patches Market, by Geography, 2016 (Value %)

Chapter 3 Global Transdermal Skin Patches Market Analysis
3.1 Global Transdermal Skin Patches Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Mergers, Acquisition and Business Strategies
3.4 Porter’s Analysis
Credence Research, Inc. 4
3.5 Attractive Investment Proposition
3.6 Competitive Analysis: Global Transdermal Skin Patches Market, 2016 (Value %)

Chapter 4 Global Transdermal Skin Patches Market Analysis, By
Product Type
4.1 Overview
4.1.1 Market Attractive Proposition of Transdermal Skin Patches Market, by
Product Type, 2016
4.1.2 Top 3 Countries
4.2 Matrix
4.3 Drug in Adhesive
4.4 Reservoir
4.5 Multilaminate

Chapter 5 Global Transdermal Skin Patches Market Analysis, By
Application Type
5.1 Overview
5.1.1 Market Attractive Proposition of Transdermal Skin Patches Market, by
Application Type, 2016
5.1.2 Top 3 Countries, By Application Type (US$ Mn), 2015– 2025 (Value)
5.2 Pain Relief
5.3 Nicotine Cessation
5.4 Hormone Replacement Therapy
5.5 Motion Sickness
5.6 Neurological Disorder
5.7 Cardiovascular Disorder
5.8 Others

Chapter 6 Global Transdermal Skin Patches Market, By Geography
6.1 Preface
Credence Research, Inc. 5
6.2 North America (U.S. & Canada)
6.2.1 North America Transdermal Skin Patches Market, by Product Type, 2015-
2025 (US$ Mn)
6.2.2 North America Transdermal Skin Patches Market, by Application Type,
2015-2025 (US$ Mn)
6.2.3 North America Transdermal Skin Patches Market, by Country, 2015 – 2025
(US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Transdermal Skin Patches Market, by Product Type, 2015-2025
(US$ Mn)
6.3.2 Europe Transdermal Skin Patches Market, by Application Type, 2015-2025
(US$ Mn)
6.3.3 Europe Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$
Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Transdermal Skin Patches Market, by Product Type, 2015-2025
(US$ Mn)
6.4.2 Asia Pacific Transdermal Skin Patches Market, by Application Type, 2015-
2025 (US$ Mn)
6.4.3 Asia – Pacific Transdermal Skin Patches Market, by Country, 2015 – 2025
(US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Transdermal Skin Patches Market, by Product Type, 2015-
2025 (US$ Mn)
6.5.2 Latin America Transdermal Skin Patches Market, by Application Type,
2015-2025 (US$ Mn)
6.5.3 Latin America Transdermal Skin Patches Market, by Country, 2015 – 2025
(US$ Mn)
6.6 Middle East and Africa
Credence Research, Inc. 6
6.6.1 Middle East and Africa Transdermal Skin Patches Market, by Product
Type, 2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Transdermal Skin Patches Market, by Application
Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Transdermal Skin Patches Market, by Country,
2015 – 2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 ProSolus, Inc.
7.3 Medipatch, Inc,
7.4 AdhexPharma
7.5 Aneva Drug Delivery Systems
7.6 Medherant Limited
7.7 Allergan plc
7.8 NITTO DENKO CORPORATION
7.9 Mylan Pharmaceutical, Inc.
7.10 Corium International, Inc.
7.11 Noven Pharmaceuticals, Inc.
7.12 Teva Pharmaceuticals, Inc.
7.13 Johnson & Johnson, Inc.
7.14 Access Pharmaceuticals Inc.
Credence Research, Inc. 7

List of Figures

FIG. 1 Transdermal Skin Patches Market: Research Methodology
FIG. 2 Transdermal Skin Patches Market, by Product Type, 2016 (US$ Mn)
FIG. 3 Transdermal Skin Patches Market, by Application Type, 2016 (US$ Mn)
FIG. 4 Transdermal Skin Patches Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition
FIG. 6 Competitive Analysis: Global Transdermal Skin Patches Market, 2016 (Value %)
FIG. 7 Global Matrix Market(US$ Mn), 2015-2025
FIG. 8 Global Drug in Adhesive Market(US$ Mn), 2015-2025
FIG. 9 Global Reservoir Market (US$ Mn), 2015-2025
FIG. 10 Global Multilaminate Market (US$ Mn), 2015-2025
FIG. 11 Global Pain Relief Market(US$ Mn), 2015-2025
FIG. 12 Global Nicotine Cessation Market(US$ Mn), 2015-2025
FIG. 13 Global Hormone Replacement Therapy Market (US$ Mn), 2015-2025
FIG. 14 Global Motion Sickness Market (US$ Mn), 2015-2025
FIG. 15 Global Neurological Disorder Market (US$ Mn), 2015-2025
FIG. 16 Global Cardiovascular Disorder Market(US$ Mn), 2015-2025
FIG. 17 Global Others Applications Market(US$ Mn), 2015-2025

List of Tables

TABLE 1 Top 3 Countries, By Product Type (US$ Mn), 2015– 2025 (Value)
TABLE 2 Global Transdermal Skin Patches Market, By Product Type (US$ Mn), 2015– 2025 (Value)
TABLE 3 Top 3 Countries, By Application Type (US$ Mn), 2015– 2025 (Value)
TABLE 4 Global Transdermal Skin Patches Market, By Application Type (US$ Mn), 2015– 2025 (Value)
TABLE 5 Global Transdermal Skin Patches Market, by Geography, 2015 – 2025 (US$ Mn) Credence Research, Inc. 8
TABLE 6 North America Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 8 North America Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 14 Asia – Pacific Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Transdermal Skin Patches Market, by Application Type, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Transdermal Skin Patches Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Transdermal Skin Patches Market, by Applications Type, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Transdermal Skin Patches Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 22 ProSolus, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 23 Medipatch, Inc,: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 24 AdhexPharma: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 25 Aneva Drug Delivery Systems: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) Credence Research, Inc. 9
TABLE 26 Medherant Limited: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 27 Allergan plc: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 28 NITTO DENKO CORPORATION: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 29 Mylan Pharmaceutical, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 30 Corium International, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 31 Noven Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 32 Teva Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 33 Johnson & Johnson, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 34 Access Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)

Frequently Asked Question:

What is the size of Transdermal Skin Patches Market?

The Transdermal Skin Patches Market is expected to see significant CAGR growth over the coming years, at 4.2%.

What is the Transdermal Skin Patches Market CAGR?

The Transdermal Skin Patches Market is expected to see significant CAGR growth over the coming years, at 4.2%.

What is the Forecast period considered for Transdermal Skin Patches Market?

The report is forecasted from 2017 -2025.

What is the base year considered for Transdermal Skin Patches Market?

The base year of this report is 2016.

Who are the major players in this market?

Abbott Laboratories,ProSolus, Inc.,Medipatch, Inc,,AdhexPharma,Aneva Drug Delivery Systems. are some of the major players in the global market.

Dialyzer Reprocessing Machines and Concentrates Market

Published:
Report ID: 43654

Patient Positioning Accessories Market

Published:
Report ID: 43647

Brain Health Devices Market

Published:
Report ID: 3445

CSF (Cerebrospinal Fluid) Management Market

Published:
Report ID: 12389

Hypodermic Needles Market

Published:
Report ID: 6174

Implantable Infusion Pumps Market

Published:
Report ID: 12455

Medical Robots Market

Published:
Report ID: 42360

Magnetic Resonance Imaging (MRI) Systems Market

Published:
Report ID: 7815

Medical Device Technologies Market

Published:
Report ID: 42130

Transfection Reagents Market

Published:
Report ID: 41609

Intracranial Stents Market

Published:
Report ID: 7131

Hot And Cold Therapy Packs Market

Published:
Report ID: 7187

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN